ProveIt Supplements

Independent, evidence-based supplement analysis.

✓ Not Sponsored

✓ No Paid Reviews

✓ Science-Based

Company

  • About Us
  • Our Methodology
  • Contact
  • Blog
  • Authors

Legal

  • Privacy Policy
  • Terms of Service
  • Medical Disclaimer
  • Affiliate Disclosure

Resources

  • All Categories
  • Ingredient Database
  • Browse Supplements
  • FAQ

© 2025 ProveIt Supplements. All rights reserved.

Medical Disclaimer: The information provided is for educational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional before starting any supplement regimen.

Prove It
Browse SupplementsBlogAuthorsAboutMethodologyFAQ
Get Your Personalized Supplement StackSupplement Stack Quiz
Menu
HomeBrowse SupplementsBlogAuthorsAboutMethodologyFAQ
Back

Dahamool Extract

Also known as: Dashmool, Dashamoola, Dashmoola Extract, Dahamool Extract

Overview

Dashamoola is a classical Ayurvedic polyherbal formulation, not a single botanical extract, composed of the roots of ten medicinal plants. These plants include Bilva, Agnimantha, Shyonaka, Patala, and Gambhari, among others. Traditionally used in Indian medicine, Dashamoola is primarily valued for its anti-inflammatory, analgesic, and neuroprotective properties. It is commonly employed in the management of inflammatory conditions, pain relief, and neurological rehabilitation, particularly in cases of stroke recovery and diabetic neuropathy. The formulation is administered in various forms, such as decoctions, powders, or medicated enemas (Basti). While its use is deeply rooted in tradition, research into Dashamoola is ongoing, with several clinical trials and systematic reviews existing, predominantly within Ayurvedic research contexts. The quality of evidence is mixed, with some systematic reviews and meta-analyses including Dashamoola among other Ayurvedic herbs, though high-quality randomized controlled trials specifically on Dashamoola alone are still limited.

Benefits

Dashamoola offers several evidence-based benefits, primarily in neurological and pain management contexts. For stroke rehabilitation, preliminary clinical data and a recent trial protocol suggest that Dashamoola Basti (medicated enema) used as an adjuvant to standard care may significantly improve sensorimotor function, balance, and gait parameters, as well as reduce stroke severity scores in patients. This indicates its potential to aid recovery and functional improvement post-stroke. In the context of neuropathic pain and diabetic neuropathy, Dashamoola extract has shown promise in providing symptomatic relief, potentially reducing pain and improving nerve function. Beyond these specific applications, Dashamoola is traditionally recognized for its anti-inflammatory and analgesic effects, which have been supported by preclinical and some clinical studies, validating its historical use for musculoskeletal pain and inflammation. While quantitative effect sizes for Dashamoola alone are not consistently reported, meta-analyses of Ayurvedic herbs that include Dashamoola suggest moderate benefits. The main populations that appear to benefit most are stroke patients and individuals suffering from diabetic neuropathy. Clinical studies have observed improvements within weeks to months, with follow-up periods ranging from 2 to 24 months.

How it works

Dashamoola's mechanism of action is complex due to its polyherbal nature, involving multiple phytochemicals acting synergistically. Its anti-inflammatory effects are believed to stem from the modulation of various cytokines and inflammatory mediators, thereby reducing the body's inflammatory response. The neuroprotective properties are possibly attributed to its antioxidant activity, which helps combat oxidative stress, and its potential to enhance nerve regeneration. Primarily, Dashamoola interacts with the nervous system and musculoskeletal system, and it may also influence the immune response. The exact molecular targets are not fully elucidated, but the combined action of its constituent herbs likely contributes to its therapeutic effects on inflammatory and neural pathways. Data on absorption and bioavailability are limited, as these factors depend on the specific preparation method and route of administration (e.g., oral vs. Basti), with Basti potentially offering more targeted effects by bypassing first-pass metabolism.

Side effects

Dashamoola is generally considered safe when used traditionally, and clinical studies have reported good tolerability. The most commonly reported side effect is mild gastrointestinal discomfort, which occurs occasionally. Uncommon or rare severe adverse events have not been reported in controlled studies, suggesting a favorable safety profile. However, it is important to note that rigorous, comprehensive safety data, particularly from large-scale, long-term studies, are limited. Drug interactions with Dashamoola are not well studied; therefore, caution is advised, especially when it is combined with conventional medications such as anticoagulants or other central nervous system (CNS)-active drugs. Specific contraindications are not clearly defined, but due to a lack of sufficient data, caution is recommended for pregnant and lactating individuals. While stroke patients and individuals with diabetes have been studied with Dashamoola without major safety concerns, it is always prudent to consult a healthcare provider before starting any new supplement, especially for those with pre-existing conditions or those on other medications.

Dosage

The optimal dosage for Dashamoola is not standardized and varies significantly depending on the specific preparation, the condition being treated, and the clinical protocol. For instance, in stroke rehabilitation, Dashamoola Basti protocols utilize specific volumes and concentrations tailored to individual patient needs. While traditional Ayurvedic texts provide general dosing guidelines, clinical trials often employ varying dosages, making it difficult to establish a universal recommendation. There is no established minimum effective dose or maximum safe dose in modern scientific literature, and no toxicity studies defining upper limits have been found in high-quality research. Dashamoola is often administered daily or multiple times per week, particularly during rehabilitation phases. It is available in various forms, including oral powders, decoctions, and medicated enemas (Basti). The preparation method and route of administration significantly influence its bioavailability and potential effects, with Basti potentially offering more targeted benefits in neurological conditions by bypassing first-pass metabolism. No specific cofactors are clearly identified as required for its efficacy.

FAQs

Is Dashmool extract effective for stroke rehabilitation?

Preliminary clinical evidence supports its use as an adjuvant with physiotherapy to improve motor and balance functions in stroke patients, though more research is needed.

Is it safe for diabetic neuropathy?

Studies suggest it may provide symptomatic relief with good tolerability for diabetic neuropathy, but further rigorous trials are necessary to confirm efficacy and safety.

How soon can benefits be expected?

Improvements may be observed within weeks to months, depending on the specific condition being treated and the overall treatment regimen.

Can it be combined with conventional medicines?

Caution is advised due to limited data on drug interactions. Always consult a healthcare provider before combining Dashamoola with conventional medications.

Research Sources

  • https://pmc.ncbi.nlm.nih.gov/articles/PMC11016165/ – This article describes a clinical trial protocol for evaluating Dashamoola Basti as an adjuvant therapy in stroke rehabilitation. Preliminary data suggest that this traditional Ayurvedic treatment may improve sensorimotor function, balance, and gait parameters in stroke patients, indicating its potential as a complementary therapy.
  • https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2022.821810/full – This systematic review and meta-analysis of herbal therapies, including Dashamoola, for systemic conditions found that these treatments, including Dashamoola, showed moderate benefits. The study highlights the potential of herbal interventions but also notes heterogeneity among the included studies, suggesting varied quality and direct applicability.
  • https://pmc.ncbi.nlm.nih.gov/articles/PMC8229657/ – This systematic review and meta-analysis on Ayurvedic herbs, which includes Dashamoola, indicates that these herbs generally demonstrate efficacy and safety. Dashamoola is specifically mentioned among herbs with neuroprotective effects, supporting its traditional use in neurological conditions, though direct evidence for Dashamoola alone is limited.
  • https://nanobioletters.com/wp-content/uploads/2020/02/2284680891853860.pdf – This narrative review focusing on the management of diabetic neuropathy suggests that Dashamoola extract may help alleviate neuropathic symptoms. While it points to potential benefits, the review also highlights the current lack of specific randomized controlled trials directly investigating Dashamoola for this condition, indicating a need for more rigorous research.

Supplements Containing Dahamool Extract

Migrahills by Herbal Hills
83

Migrahills

Herbal Hills

Score: 83/100
Migrahills by Herbal Hills
38

Migrahills

Herbal Hills

Score: 38/100